Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02504918
What this trial is testing

Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian Children

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 200
Early research (Phase 1)Study completedNCT00292929
What this trial is testing

Study of the Safety of Intravenous Artesunate

Who this might be right for
MalariaMalaria, Cerebral
U.S. Army Medical Research and Development Command 40
Early research (Phase 1)UnknownNCT01645254
What this trial is testing

Phase 1b Malaria Clinical Trial Using Argemone Mexicana in Healthy Adults in Mali

Who this might be right for
Malaria
University of Bamako 24
Post-approval studies (Phase 4)Study completedNCT02251704
What this trial is testing

Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 54,115
Large-scale testing (Phase 3)Study completedNCT01148459
What this trial is testing

Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children

Who this might be right for
Malaria
GlaxoSmithKline 200
Post-approval studies (Phase 4)UnknownNCT04778813
What this trial is testing

Evaluation of Three Artemisinin-based Combinations for the Treatment of Uncomplicated Malaria in Childreen in Burkina Faso (CHIMIO2)

Who this might be right for
MalariaBurkina Faso
Centre national de recherche et de formation sur le paludisme 1,050
Testing effectiveness (Phase 2)Study completedNCT02431650
What this trial is testing

Effectiveness of OZ439 as a Gametocytocidal and Transmission Blocking Agent

Who this might be right for
Malaria
Medicines for Malaria Venture 11
Post-approval studies (Phase 4)Study completedNCT04618523
What this trial is testing

Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo

Who this might be right for
Malaria
Ministry of Public Health, Democratic Republic of the Congo 1,117
Early research (Phase 1)Study completedNCT01624961
What this trial is testing

Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults

Who this might be right for
Malaria
Sanaria Inc. 30
Large-scale testing (Phase 3)Study completedNCT00866619
What this trial is testing

Efficacy of GSK Biologicals' Candidate Malaria Vaccine 257049 Against Malaria Disease in Infants and Children in Africa

Who this might be right for
Malaria
GlaxoSmithKline 15,459
Not applicableStudy completedNCT00772642
What this trial is testing

Immune Parameters in the Cord Blood of Newborns Exposed to Malaria in the Womb

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)Study completedNCT01556945
What this trial is testing

Safety and Preliminary Efficacy of the Malaria Vaccine Candidates Falciparum Merozoite Protein-1 (FMP1) and SmithKlineBeecham (SKBB) Candidate Malaria Vaccine RTS,S

Who this might be right for
Malaria, Falciparum
U.S. Army Medical Research and Development Command 72
Early research (Phase 1)Study completedNCT06652737
What this trial is testing

Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Who this might be right for
Malaria FalciparumMalaria Infection
Sanaria Inc. 75
Not applicableStudy completedNCT00138372
What this trial is testing

Human Immunity to MSP-1 in Western Kenya

Who this might be right for
Plasmodium Falciparum Malaria
Case Western Reserve University 475
Large-scale testing (Phase 3)UnknownNCT04844905
What this trial is testing

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

Who this might be right for
Malaria,FalciparumNeglected Tropical DiseasesStrongyloidiasis+4 more
London School of Hygiene and Tropical Medicine 24,000
Early research (Phase 1)Not Yet RecruitingNCT07646353
What this trial is testing

First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 40
Testing effectiveness (Phase 2)UnknownNCT00652275
What this trial is testing

Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine

Who this might be right for
Malaria
African Malaria Network Trust 378
Not applicableStudy completedNCT00203801
What this trial is testing

Combination Antimalarials in Uncomplicated Malaria

Who this might be right for
Malaria
University of Cape Town 700
Post-approval studies (Phase 4)UnknownNCT05340153
What this trial is testing

Efficacy and Safety of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Cameroon

Who this might be right for
Malaria
University of Yaounde 1 184
Early research (Phase 1)Study completedNCT00343005
What this trial is testing

Experimental Vaccine for Malaria in Adults in Mali

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 54
Next Page